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Abstract
Background: Within healthcare, almost no attention is given to patients with moderate-to- severe chronic kidney
disease, having a with GFR between 20 and 45 while the presumption exists that these patients already experience
several problems in their lives during the course of their illness.
Methods: A team of academic researchers and a renal patient participated in a qualitative study. Individual interviews
(n = 31) and focus groups (10 participants in total) with patients having moderate-to-severe chronic kidney disease
were conducted to gain insight into their everyday problems.
Results: Participants mentioned several experiences that can be divided into physical, social, societal and psychological
aspects as well as aspects related to healthcare. The most important findings, following under each of these categories
are: 1) the experience of fatigue (physical aspects) 2) the search for acknowledgment of complaints/not enough
attention given to complaints leading to overcompensation and secrecy (societal aspects) 3) work problems
(societal aspects) and 4) the wish to control the disease but not receiving enough support for this (healthcare).
Patients feel in general that healthcare professionals do not take them seriously in their complaints and problems.
Conclusions: This study offers important new insights into an expanding group of patients having moderate-to-severe
chronic kidney disease. Healthcare professionals should acknowledge their problems instead of ignoring or rejecting
them and they should support patients in finding a way to deal with them. The assumptions of Personalised Care
Planning could be used to support patients.
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Background
Chronic Kidney Disease (CKD), defined by reduced
Glomerular Filtration Rate (GFR) and/or increased urin-
ary albumin excretion [1] is a problem with an increas-
ing incidence and prevalence and high costs (http://
www.kidney.org, http://ekha.eu/) [2]. The prevalence is
estimated to be 8–16 % worldwide [1]. One potential
outcome of CKD is End-Stage Renal Disease (ESRD), re-
quiring renal replacement therapy like dialysis or
transplantation.
The Dutch Kidney Patient Association (NVN) has
heard from their members that professionals in the
Netherlands adhere to the assumption that complaints
related to CKD only arise if GFR is lower than 20 or 30
and when a renal replacement therapy is about to start
(pre-dialysis stage). This is also stated in patient educa-
tion materials for instance from the Dutch Kidney Foun-
dation (www.nierstichting.nl). A search on the Internet
shows not only a Dutch tendency but also a more wide-
spread tendency to adhere to the assumption that com-
plaints only arise if the GFR drops below 30. Medscape,
a Health Professional Network that offers specialists, pri-
mary care physicians and other health professionals and
the Internet’s most robust and integrated medical infor-
mation and educational tools, for instance mentions that
‘Patients with CKD stages 1–3 (GFR >30 mL/min/
1.73 m2) are generally asymptomatic’ (http://emedicine.-
medscape.com/article/238798-overview).
Based on input from their members, the patient associ-
ation became aware that this assumption might be incor-
rect and that CKD patients can experience complaints
much earlier. This is also suggested by the literature; high
mortality rates and prevalence of comorbid conditions,
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even in patients at earlier stages of CKD have been re-
ported [3]. Members of the association requested atten-
tion for patients with moderate-to-severe CKD (GFR 20–
45), their Quality of Life (QoL) and their experienced
problems since they felt neglected by the association and
professionals.
The existing literature consists of very few studies
on the experiences of patients with moderate to severe
CKD (stages 1–3) and their QoL. Most of the studies
focus on patients with advanced CKD (stages 4 and 5)
[3]. Based on those studies, we know that the Health
Related Quality of Life (HRQOL) in patients with
advanced CKD (stage 4 and 5) is significantly impaired
[3]. The studies conducted on the QoL of patients in
stages 1–3 describe a decreased HRQOL among
patients with mild-to-moderate renal dysfunction
compared with the population having normal renal
function [3].
The QoL of patients with CKD is thus lower than is
the QoL of people without CKD. One may expect that
the QoL of patients decreases with a decreasing GFR
but studies on this relationship give conflicting results.
Lee and colleagues included 5555 patients with CKD
stages 1–3 in a study. They described a relationship be-
tween QoL and GFR: a lower GFR is related to a lower
QoL [3]. Lemos and colleagues have however described
other results. They investigated 170 patients with CKD
at stages 1–5 (not on dialysis yet) and concluded that
the degree of renal function did not influence QoL [4].
Gender, age and family income were, however, described
as affecting QoL [4].
The quantitative literature does teach us something
about the QoL of patients with CKD. In these studies,
QoL seems to be impaired in all stages of the disease
and it is unclear whether or not there is a strong relation
between GFR and QoL [3, 4]. Gender, age and family in-
come seems to be important factors that influence QoL
[4]. These insights are important but do not give us
insight into the profound experiences of patients living
with CKD and the factors that may influence their QoL.
Qualitative studies can be helpful for a more profound
understanding [5]. The literature describes several quali-
tative studies, for instance, on experiences with dialysis,
experiences with living-related transplantation and living
with a kidney transplant. However, studies on the impact
of living with less advanced CKD and how patients ex-
perience their QoL and what they need in order to stay
physically and mentally as healthy as possible, are lack-
ing. Insight into patients’ experiences, coping, QoL and
needs is important to fine-tune their care and to provide
the necessary support. We, therefore, performed a quali-
tative study aimed at describing the experiences and




Patients were eligible to participate if they had a GFR
between 20 and 45 for at least 3 months, were not yet at
the pre-dialysis/pre-transplantation stage and were be-
tween 18 and 80 years old. The inclusion criterion of a
GFR between 20 and 45 was strongly recommended by
the scientific advice committee of the funder, the Dutch
Kidney Foundation. The members of the committee (ne-
phrologists) asked us to combine stage 2, 3 and 4 in
order to get a more similar group with less diverging
experiences.
The NVN, hospitals and the Facebook page for the
Dutch Kidney Foundation were used to recruit partici-
pants. The sampling for our method of recruitment in
this study was purposeful as we were selecting a rich
variety of patients in terms of age, gender, GFR, hospital
in which patients were treated, method of recruitment
in this study (patient association, Facebook, hospitals)
[6]. Patients were asked to report their latest GFR as
measured by their medical doctor to check whether they
actually met inclusion criteria. All patients that were dir-
ectly asked by the NVN and professionals to participate
were willing to participate in an interview or focus
group. The research team, taking the criteria into ac-
count, made the selection of participants from those
willing to participate.
Data collection and data analysis
A team consisting of academic researchers and a renal
patient conducted the study.
Actively including patients as partners in research has
several advantages such as establishing trust and open-
ness [7–13].
In the first part of the study, 31 semi-structured inter-
views were completed by one of the academic re-
searchers (psychologists and anthropologist) and the
patient researcher [11].
The academic researchers previously participated in
courses on how to conduct qualitative studies and all in-
terviewers were experienced in conducting qualitative
studies. They took general quality criteria for the semi-
structured interviews into account, such as asking open-
ended questions, using different probes and avoiding
jargon [14]. The interviews were aimed at obtaining
insight into the experiences of patients. Participants’
stories led the interviews and a list of topics (Appendix
1) was used to check whether all topics were discussed.
The interviews lasted between 60 and 120 min and were,
after respondents’ verbal consent, audio-recorded and
transcribed verbatim.
All interview transcripts were subjected to a thematic
analysis [15]. First, all of the entire transcripts were read
line by line and emerging themes were coded. New
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themes in the transcripts were added to the list of codes
and then used to re-analyse the interviews that had already
been analysed. A mix of computerised (MAXQDA) and
manual techniques was used to facilitate data analysis. To
enhance credibility, we adhered to the following proce-
dures: 1) two researchers separately coded all interviews
(investigator triangulation) [16], 2) all individual analyses
were compared and discussed until consensus was
reached [17] and 3) participants received an interpretation
of the interview and were asked whether they recognised
the analysis (member-check) [17]. All patients agreed. The
themes of all interviews were grouped and further ex-
plored in two focus groups with other participants (2 × n
= 5, in total n = 10). Focus groups can be used to deepen,
explain or check data. The entire research team prepared
the focus groups and a senior researcher (KS) led them,
using a protocol (see Appendix 2).
After three interviews, it became clear that fatigue
seemed to be an important complaint of the participants.
The interviews were not analysed yet, but fatigue was a
prominent theme in the three interviews. To gain better
insight into the fatigue experienced, we decided to add
the Checklist Individual Strength to measure the experi-
enced fatigue [18]. All patients, including the first three
patients, were asked to fill out the questionnaire after
the interview or focus group. In all, 32 patients returned
the questionnaire (response rate 78 %).
Ethical considerations
The Medical Ethics Committee approved this study (in-
cluding the questionnaire), and the procedures followed
were in accordance with the ethical standards of the
Medical Ethics Committee of the VU Medical Center.
All participants voluntarily took part and none of them
declined our request to participate. All participants gave
verbal informed consent. Confidentiality was maintained
by restricted, secure access to the data, destruction of
audiotapes following transcription and de-identifying the
transcripts.
Results
In total, 41 patients participated in this study. An over-
view of the participants’ characteristics in the interviews
and focus groups are presented in Tables 1, 2 and 3.
The interviews and focus groups resulted in an over-
view of experiences. Participants mentioned several ex-
periences that can be divided into physical, social,
societal and psychological aspects as well as aspects re-
lated to healthcare. An overview of the aspects and its
subthemes is given in Table 4. All of these themes are
described below. The findings are illustrated, using the
participants’ quotes. Each quotation is marked with the
number of the participant as well as their gender, age
range and GFR.
Physical aspects
A few participants did not experience any physical
problems, but the majority of the participants men-
tioned several complaints. Problems expressed were fa-
tigue, concentration and memory problems, cramp,
being unfit, feeling cold, gout, restless legs, kidney pain
and itching. Fatigue was mentioned as the most prob-
lematic complaint:
‘My battery is full when I wake up in the morning, but
my battery runs low during the day’. (R6, F, 26–35
years, GFR 45)
Table 1 Characteristics patients interviews (n = 31)
Respondent Gender Age range Stage CIS fatigue
R1 F 36–45 3b -
R2 F 46–55 4 Severe
R3 M 46–55 3b -
R4 F 56–65 4 Normal
R5 F 26–35 4 Severe
R6 F 26–35 3a Severe
R7 F 56–65 4 Severe
R8 F 36–45 4 Severe
R9 F 46–55 4 Severe
R10 F 56–65 3b Severe
R11 F 18–25 3b Severe
R12 M 36–45 4 Severe
R13 M 26–35 4 Severe
R14 F 46–55 4 Severe
R15 M 26–35 4 Severe
R16 M 36–45 4 Severe
R17 M 66–75 3b Normal
R18 M 56–65 3b -
R19 F 46–55 4 -
R20 F 36–45 3b Severe
R21 M 46–55 4 -
R22 F 36–45 3b -
R23 F 36–45 4 -
R24 F 46–55 4 -
R25 M 46–55 3a -
R26 M 18–25 3b Severe
R27 F 46–55 3b Severe
R28 M 26–35 3b Severe
R29 F 56–65 3b -
R30 F 56–65 4 -
R31 M 56–65 4 -
Stage 3A: GFR between 45 and 59, stage 3B: GFR between 30 and 44 and
stage 4: GFR 15–29 (in our study no GFR’s lower than 20)
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‘I can’t describe it. How to describe fatigue? For me it
is having sudden moments without having any energy
and without being able to do anything’. (R4, F, 56–65
years, GFR 23)
This qualitative finding was validated by the CIS-
Fatigue questionnaire. A total of 75 % of the partici-
pants (including those with lower and those with
higher GFR) who filled out the questionnaire experi-
enced severe fatigue.
The accumulation of physical problems was expressed
as a ‘never-ending story’, which was hard to deal with:
‘The most difficult part of having CKD is the fact that
it never stops. It is a never-ending story and you are
running from problem to problem. It’s an accumulation’.
(R14, F, 46–55 years, GFR 20)
Dealing with the problems was especially difficult be-
cause participants did not know whether to attribute the
complaints to the disease or to isolated problems:
‘Is it a direct consequence of your disease or is it the
result of other circumstances? It’s hard to make that
distinction’. (R32, M, 46–55 years, GFR 45)
Social aspects
Growing up
Having CKD as a child influenced the dynamics of child-
hood and adolescence. Participants had to make other
choices and were not able to follow the same route as
their peers. They felt that they were treated as being dif-
ferent and that the environment usually did not adjust
to their illness. Their possibilities and capacities declined
because of the illness, while the possibilities of their
peers increased:
‘I had to make other choices, I wasn’t able to follow
their [peers] paths’. (R38, M, 36–45 years, GFR 27)
Table 2 Characteristics patients focus groups (n = 10)
Respondent Gender Age range Stage CIS fatigue
R32 M 46–55 3a Severe
R33 F 56–65 3b Normal
R34 M 56–65 3a Severe
R35 F 56–65 4 Normal
R36 M 56–65 3b Normal
R37 M 66–75 3b Normal
R38 M 36–45 4 Severe
R39 F 36–45 3b Severe
R40 F 56–65 3b Severe
R41 F 46–55 4 Severe
Stage 3A: GFR between 45 and 59, stage 3B: GFR between 30 and 44 and
stage 4: GFR 15–29 (in our study no GFR’s lower than 20)
Table 3 Characteristics patients interviews and focus groups
(n = 41)
Percentage
Age 18–25 4,9 %
Age 26–35 12,2 %
Age 36–45 24,4 %
Age 46–55 24,4 %
Age 56–65 29,2 %
Age 66–75 4,9 %
Women 59 %
Men 41 %
GFR 20–29 49 %
GFR 30–45 51 %
Stage 3A 9,8 %
Stage 3B 41,5 %
Stage 4 (not lower than GRF 20) 48,7 %
Score severe fatigue on CIS-fatigue 75 %
Score severe fatigue on CIS-fatigue with GFR 20–29
(16 persons had a GFR between 20 and 29 and filled
out the questionnaire)
(75 %)
Score severe fatigue on CIS-fatigue with GFR 30–45
(16 persons had a GFR between 30 and 45 and filled
out the questionnaire)
75 %
Table 4 Overview of themes and subthemes
Theme Subthemes
Physical aspects -
Social aspects Growing up
Intimate relationships and sexuality
Desire to have a child
Family life and raising children
Social contacts
Societal aspects Ignorance and image formation
Trivialising
Pressure to legitimate
Fear of stigmatisation and prejudice
Embarrassment and identity
Education, work and social security
Healthcare Education
Contact with professionals
Multidisciplinary care and self-management
Experimental care and future treatment
Psychological aspects Deterioration - insecurity and trust
Coping
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Intimate relationships and sexuality
The illness may influence the intimate relationships of
patients. Lack of communication was mentioned as one
of the causes of relational problems and in some cases,
CKD led to divorce. Finding new intimate relationships
was also described as difficult. Participants mentioned
their doubts about the question ‘what to tell and what
not to tell?’ They were afraid of losing their potential
partner due to the disease. Some participants actually
experienced people being scared off by the disease:
‘It was scary to tell my current boyfriend about the
disease. I was afraid that he would leave me’. (R20, F,
36–45 years, GFR 42)
Fears for the future were also expressed. Participants
feared for the continuation and endurance of their in-
timate relationship in the light of further progression of
the disease:
‘I can be afraid if I think about the future … Will he
still love me if I have more restrictions? And can we
stay partners on equal terms?’ (R20, F, 36–45 years,
GFR 42)
Related to that is the fact that participants mentioned
changes in their sexual functioning such as decreased li-
bido and as a result of this, for some men, there were
feelings of ‘being less masculine’:
‘You are not a real man anymore because of your
decreased libido. It feels as if I have failed’. (R16, M,
36–45 years, GFR 25)
Desire to have a child
Having CKD influenced some participants’ decisions as
to whether they did or did not want to have children.
The insecure future, the possible harmful effect of being
pregnant on kidney functioning, and heredity were taken
into account:
‘The nephrologist has said that I can have children.
But he also mentioned the risks for my kidney. So I
was thinking … We should not do it … And what can
I offer a child if I’m in hospital three times a week for
dialysis’. (R23, F, 36–45 years, GFR 35)
Some participants felt they had to defend their
choices:
‘It’s hard to defend yourself. People are always asking
why we don’t have children. They have their own
opinions and prejudices. The worst are those people
who say “that the disease isn’t that bad and that you
never know how medical science will develop”. Of
course they are right but it is my choice and I don’t
want my children to have an ill mother’. (R20, F, 36–
45 years, GFR 42)
Some female participants, however, did not have any
choice at all. They were not able to have children due to
their CKD. Other participants had difficulty becoming
pregnant and needed fertility treatment.
Family life and raising children
For those that did have children raising them may be
negatively influenced by CKD. Participants mentioned
feelings of being restricted in regard to family activities,
which led to feelings of sadness or guilt:
‘You don’t live the life you would like to live. I can’t
lead the life I envisioned for myself and my kids. … I’m
just trying to survive’. (R22, F, 36–45 years, GFR 35)
Furthermore, they did not like the fact that their chil-
dren had to deal with the consequences of their disease.
They found it important that their children should be
allowed to be children, despite the disease of one of their
parents. However, this ideal turned out to be difficult or
sometimes impossible. In some cases, this gave rise to
tensions between parents since their children expressed
their dissatisfaction to the healthy parent.
Finally, participants expressed concerns about the feel-
ings of the healthy partner (is he/she able to deal with
my disease?) and possible heredity (do my children have
the same disease or not?):
‘Ï’m worrying about my wife since she has to deal with
my disease and the worries about the potential disease
of our children’. (R18, M, 56–65 years, GFR 39)
Social contacts
CKD influenced social contacts, often in a negative way.
Friendships were lost, because participants did not have
enough energy to be an active partner in friendships or
to be involved in activities. Work was stressed as being
important for social contacts:
‘Conversations at parties stagnate when you say that
you don’t work’. (R10, F, 56–65 years, GFR 38)
Losing work due to CKD often resulted in losing
contacts. Some participants were afraid of losing
friends in advance, but the reality was not as bad as
they had anticipated. Other participants explained how
they consciously chose to maintain fewer friendships.
Having fewer friends made it easier to keep in touch
with those contacts:
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‘I used to have many friends and my network was
getting bigger and bigger. And I assumed that I needed
to maintain all these contacts. But I’m no longer able
to do that so I had to make choices: who is really
important to me and who is not? Who are the people I
want to give my time and energy to and who are not’?
(R6, F, 26–35 years, GFR 45)
Societal aspects
Ignorance and image formation
Many participants expressed their struggle with existing
ideas about CKD in society. Those around the inter-
viewees were often perceived as associating CKD with
dialysis or transplantation. Participants often perceived
those in their environment as being unaware of the
problems of this particular category of patients:
‘People think about dialysis or transplantation when I
say that I’m a renal patient. They don’t know the
other options. It is not seen as renal disease if you are
not on dialysis or if you don’t have a donor kidney’.
(R9, F, 46–55 years, GFR 26)
Trivialising
Some participants do not feel that their complaints are
taken seriously, in part due to inadequate image forma-
tion: ‘it cannot be that bad if you are not dialysing yet’.
The participants themselves, on the other hand, also
tend to trivialise their disease and complaints by com-
paring their disease with more severe diseases, such as
cancer, although the prospects of many forms of cancer
are better compared to CKD:
‘I don’t want to bother other people. It would be
different if you had cancer’. (R37, M, 66–75 years,
GFR 30)
Pressure to legitimate
Participants often do not feel taken seriously by profes-
sionals. They were lacking the acknowledgement of
professionals:
‘I don’t tell my nephrologist my problems any more.
She will not take them seriously’. (R41, F, 46–55 years,
GFR 20)
In part due to this attitude of professionals, invisibility,
unfamiliarity and trivialising, participants mentioned
pressure to defend themselves and their complaints.
Sometimes, they felt they had to persuade others that
their complaints were real, not the same as those experi-
enced by others (everyone is fatigued sometimes) and
not faked. Patients and the people in their environment
struggled with the legitimacy of the disease.
‘People don’t realise the impact of having this disease.
They tend to ignore it and I think they see me as
someone who fakes it’. (R22, F, 36–45 years, GFR 35)
‘I felt guilty and I felt that I had to defend myself
constantly towards others’. (R8, F, 36–45 years, GFR 23)
Fear of stigmatisation and prejudice
Some participants lived a life full of secrets: they did not
want those in their environment to know about their
disease because they worried about the consequences,
such as losing their job:
‘My colleagues and employer don’t know that I have
CKD. I’m afraid they will use it against me’. (R20, F,
36–45 years, GFR 42)
Participants also expressed fear of being stigmatised,
facing prejudice or of no longer being taken seriously:
‘I don’t want to have the “stamp” patient, because I
don’t feel like a patient right now’. (R32, M, 46–55
years, GFR 45)
Embarrassment and identity
Some participants expressed embarrassment because
of their disease, their restrictions or required devices,
especially those with physical restrictions. The disease
and losses also negatively influenced their identity.
Some participants mentioned feelings of being worth-
less, useless and dismissed since they lost a lot as a
result of their CKD:
‘I used to be [name] from my job, then from the horses
and now … now I’m [name] from nothing. I’m
nothing’! (R41, F, 46–55 years, GFR 20)
They further expressed how the disease changed their
attitude/way of behaving in contacts with others. In
some cases, this gave rise to feelings of insecurity, such
as ‘does the other person like the new me’?:
‘I sometimes wonder: do they still like me? They know
me as the one dancing on the tables. I’m now the one
who is sitting in a corner, chatting and drinking
somewhat. People are going to see another part of you
that is getting bigger and bigger than the part of you
they used to know’. (R6, F, 26–35 years, GFR 45)
Education, work and social security
Many participants were no longer able to work or
were only able to work part-time, which could lead to
financial pressure. Fatigue was the most common rea-
son for this:
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‘I was working full-time; it was too heavy. I fell asleep
during my work! Really embarrassing’! (R5, F, 26–35
years, GFR 20)
Making the choice to stop working or to decrease the
number of hours was experienced as a tough decision that
led to various feelings, such as the feeling of losing every-
thing and being put aside to feelings of being relieved or
feeling empty. Work was often described as important
since it gave people a sense of identity. As a result, some-
times participants tried to do their best to keep working.
Maintaining a job was also important since people did not
want to receive alimony or have financial problems. Re-
ceiving alimony was associated with financial problems
and with embarrassment and fear of prejudice:
‘It is a negative label that is put on your forehead’.
(R41, F, 36–45 years, GFR 20)
Participants abandoned other activities and social con-
tacts just so that they could work as much as possible.
They became exhausted and did not have sufficient en-
ergy for other activities, which led to the question: ‘do I
want this?’:
‘I really want to continue working but I don’t have the
energy for other things. I’m not sure anymore if work is
worth all the sacrifices’. (R27, F, 46–55 years, GFR 38)
Workplace adaptations were sometimes possible, but
led to less satisfaction or a sense of loss of status. Partici-
pants also had to deal with the reactions of their employer
and company doctor. Some participants experienced a lot
of understanding whereas others did not experience much
empathy. In addition, company doctors and those con-
ducting medical examinations for social security often
know little about the impact of CKD in earlier stages:
‘The doctor who had to decide whether I was able to
work or not said: “come back if you have to start with
dialysis; for now we are not going to change anything”.’
(R23, F, 36–45 years, GFR 25)
Participants further, expressed feelings of being pun-
ished for being sick.
‘Did I choose to have this disease? I don’t think so … but
it feels like being punished’. (R8, F, 36–45 years, GFR 23)
Healthcare
Education
Participants experienced the care received as being in-
sufficient and not attuned to their needs and situation.
One problem is the lack of information after diagnosis
and during progression of the disease. Most participants
were shocked by the diagnosis, even if they knew there
was a high possibility of having the disease. Realising
that the disease is progressive and unpredictable was dif-
ficult and participants needed some time to accept the
diagnosis. They desired more information about their
disease and its consequences, but this was often lacking.
The information they received did not fit their situation
since it was focused on (pre)dialysis and transplantation:
‘The information does not fit. It’s like you fall between
two stools a little’. (R28, M, 26–35 years, GFR 39)
Contact with professionals
Patients expressed various experiences with their ne-
phrologists. Some were really satisfied whereas others
were unsatisfied. Dissatisfaction was often the result of a
lack of personal contact and being taken seriously:
‘I want to be more than my renal function. They don’t
see you as a person’. (R2, F, 46–55 years, GFR 27)
‘The nephrologist is just looking at you when you
explain your fatigue. And the only thing he does, is
telling you: “It doesn’t fit with your GFR: it doesn’t fit”.’
(R6, F, 26–35 years, GFR 45)
Multidisciplinary care and self-management
Participants lacked multidisciplinary care, for instance
from a social worker or dietician other than their phys-
ician. They also lacked self-management opportunities:
‘I knew I had to follow a diet, but nobody has ever told
me that and nobody has ever supported me starting a
diet’. (R2, F, 46–55 years, GFR 27)
Participants who received such care were more satis-
fied, but the offer often came too late so patients had to
arrange their care themselves, wondering where to find
adequate and valid care:
‘They offered me such care after years. It was too late,
I had already solved my problems on my own’. (R8, F,
36–45 years, GFR 23)
Experimental care and future treatment
Because of a lack of treatment options experienced,
some participants took part in experimental treatments/
research. By participating in such projects they hoped to
slow the progression of their disease. However, being the
subject of scientific research sometimes resulted in a
more frequent confrontation with the disease:
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‘The prospects of the medication were promising. Yes, I
jumped for joy when I could participate. It’s exciting:
you just intensely hope you may profit yourself. But
there is also another side of the medal. Every 3 months
you are being checked and informed about your blood
values. A first injection, a second injection, a subsequent
test, yet another test. You just feel like a patient and
that’s not always pleasant’. (R20, F, 36–45 years, GFR 42)
Some participants were also already thinking about fu-
ture therapies. They did not always feel supported by
professionals who did not want to give information
about future treatments or professionals who advised pa-
tients not to worry about the future:
‘The nephrologist advised me not to think about
dialysis or transplantation yet because I’m not in that
stage of the disease yet. But I know I will need it 1 day
so it’s not that easy to put all those emotions and
doubts away’. (R20, F, 36–45 years, GFR 42)
Other opposite problems arose when pre-emptive
transplantation was already mentioned as a possibility.
Professionals, according to patients, talked too easily
about finding a donor.
‘The physician said to me: “You can avoid dialysis if
you are able to find a donor”. I was looking at my
family and friends and then decided: I’m not going to
ask them! I don’t want to take the risk. What if something
happens to them’! (R5, F, 26–35 years, GFR 20)
Talking about pre-emptive transplantation was experi-
enced as difficult. Participants did not know how to
introduce the subject or they felt pressurised to find a
donor. Some participants who did ask their relatives to
become a donor had to deal with negative reactions. Par-
ticipants also found it difficult to wait for a treatment,
such as transplantation, to be carried out.
Psychological aspects
Deterioration - insecurity and trust
Patients with CKD experienced difficulties that they had
to deal with. One difficulty was dealing with a (slow) de-
crease of kidney function and insecurity about the future:
‘You are not quite sure about the possibilities of your
body, now and in the future. It is such a silent disease.
It may become worse without you noticing it’. (R27, F,
46–55 years, GFR 38)
Coping
Participants used many strategies to deal with their dis-
ease and restrictions. Most of the time they were able to
deal with the disease and its consequence and they
showed a considerable amount of resilience. Trying to
stay in control was one of the mentioned strategies. A
way of doing this was by following a diet or initiating
other lifestyle adaptations:
‘I have a diet and this makes me happy since it gives
me a sense of control: I can do something to stop the
disease’. (R27, F, 46–55 years, GFR 38)
Having no possibility to control the disease was associ-
ated with stress, whereas lifestyle adaptations provided a
sense of control:
‘There is not much I can do to stop it. My blood
pressure is good and a diet doesn’t help. Living a
healthy life is the only thing. This can be frustrating
sometimes. Something happens in your body and there
is nothing you can do, nothing but wait and see’. (R26,
M, 18–25 years, GFR 40)
Some participants however did not want to adapt their
lifestyle because they expected these changes to nega-
tively impact their quality of life:
‘My daughter is pushing me towards a diet. No
way! It is not going to happen since my quality of
life is more important than quantity’! (R18, M, 56–65
years, GFR 39)
Another way to keep a sense of control was by setting
boundaries and anticipating bodily signals. Finding and
maintaining personal boundaries were reported as time-
and energy consuming but helpful. Participants experi-
enced additional barriers because of the incomprehen-
sion of the environment and deterioration of the disease:
‘The environment doesn’t know your possibilities and
limitations. They are asking you … can you please do
this and that … And my reply: “Of course … I will do
it all”.’ (R22, F, 36–45 years, GFR 35)
Other coping strategies mentioned included focussing
on the present and possibilities instead of on the inse-
cure future:
‘I try to live day to day and see what I am able to
do right now. I tend to ignore the future a little.
Thinking about that is too overwhelming and
emotional, so I just try not to do that’. (R20, F,
36–45 years, GFR42)
This could be difficult, but it was seen as being just as
important as staying positive and hopeful:
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‘The notion that it will be more difficult in the future
is always there. I may not have many problems right
now, but the sword of Damocles is always hanging
over my head’. (R26, M, 18–25 years, GFR 40)
Humour also helped to place problems in perspective.
Communication and openness about restrictions were
also mentioned as important. Openness led to under-
standing, but it was daunting because people feared the
possible negative consequences of being open:
‘I find that difficult, being dependent or being
stigmatised. I just wanted to take part as long as
possible. Especially in the past few years, I really
crossed my limits … because I did not want to be seen
as weak’. (R4, F, 56–65 years, GFR 23)
Energy management was a final way to deal with re-
strictions. Patients tried to use their diminished energy
as effectively as possible. Making choices was reported
as being necessary but also difficult:
‘I sometimes sacrifice things—cycling, swimming, yoga—if
something else is more important to me. There are no
“must-dos” anymore’. (R4, F, 56–65 years, GFR 23)
‘These are difficult choices. What is most important to
me? Work or being able to do something in the
evenings and during the weekend’? (R26, M, 18–25
years, GFR 40)
In the end, acceptance was needed but participants
needed time to reach a state of acceptance, and some-
times acceptance was impossible for patients:
‘It is funny though, because I went from a state of
denial to total acceptance, I believe’. (R6, F, 26–35
years, GFR 45)
‘You just get it served and have to eat it like that,
whether you like it or not’. (R33, F, 56–65 years, GFR 38)
Discussion
The existing literature gives us insight into the QoL of
patients with CKD. Their QoL seemed to be decreased
in all stages of the disease [3, 4] and it is unclear
whether or not the GFR influences the QoL [3, 4].
This study gives further insight into the patients’ expe-
riences of living with moderate-to- severe CKD. Partici-
pants in this study mentioned many experiences that
had not previously been described in the literature and
are not yet sufficiently recognised in daily practice.
This study shows, in general, that living with de-
creased renal function already influences the QoL of
patients across several domains. The disease/decreased
renal function has physical, social, societal and psycho-
logical impacts and seems to influence the QoL in sev-
eral ways.
Four main findings were mentioned most often and
were emphasised the most by participants. We will dis-
cuss these findings in more detail below.
The first main finding is the fact that 75 % of the par-
ticipants who filled out the CIS questionnaire (n = 32)
reported severe fatigue on the CIS questionnaire. Fatigue
was also mentioned very often in the interviews and
focus groups. Fatigue is often described in the literature
as being very problematic in CKD, especially during dia-
lysis [19–24]. The prevalence of (severe) fatigue in dialy-
sis patients ranges from 60 to 97 % [22]. Fatigue after
transplantation has also already been described [25, 26].
Dutch patients who had received a kidney transplant
were significantly more often severely fatigued (39 %)
compared to matched controls [26].
However, prior to this study, fatigue was not men-
tioned in combination with a GFR of between 30 and
45, while this study suggests that fatigue can be seen as
a significant problem for the majority of patients with
moderate-to-severe CKD. Patients do not feel taken ser-
iously by physicians who ignore the fatigue or tend to al-
locate it to causes other than renal disease. Problems are
only expected if the GFR drops below 30, as was also de-
scribed in Dutch and international education materials
for patients. The results of this study put forth the need
for more research on fatigue in this stage of the disease,
more attention for fatigue in earlier stages of the renal
disease and the possible adaptation of education mate-
rials. Attention should also be given to the strategies
already used by patients in order to deal with their fa-
tigue. Professionals should focus their advice on the
strategies of patients in order to strengthen them.
The second related finding is that participants really
struggled with the lack of acknowledgement of their
complaints. This struggle is partly caused by the pa-
tients’ own thoughts and assumptions, the invisibility
of the disease and societal norms of economic product-
ivity and independency. It is also caused by the educa-
tion and attitude of professionals (‘you cannot have
these complaints right now; you are only allowed to
have complaints with GFR lower than 20 or 30’).
These factors led to the finding that these patients
are desperately searching for acknowledgement. If
they receive acknowledgement, they can be open
about their complaints. If they do not receive ac-
knowledgment, the patient may choose to live a life
full of secrecy. They do not want to be open, because
many have lost jobs, income and economic self-
sufficiency due to (openness about) CKD or they are
afraid this will happen.
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Searching for acknowledgment is a well-known theme
in the (illness) experiences of patients with a chronic
disease. Often, the moment of getting the diagnosis or
the diagnosis itself gives a certain form of acknowledge-
ment. The diagnosis of itself may, provide exemption
from role obligations, whereby people no longer feel
blamed for their disability [27]. In the case of moderate
CKD, this seems to work the other way around: the diag-
nosis in itself does not give enough clarification and jus-
tification of the complaints, which results in a search for
acknowledgment.
Acknowledgment of the complaints of patients by pro-
fessionals and changing education towards patients are the
first step to changing the image formation and acceptance
of this group of patients with these specific complaints.
The third main finding concerns the problems partici-
pants already experience regarding their participation in
work. Nowadays, attention is mostly given to work prob-
lems as experienced by patients in the pre-dialysis stage
(stage 4) or during dialysis (stage 5). The literature
shows that people on dialysis have problems combining
their treatment with a paid job; participation rates of
around 24 % in dialysis patients aged below 65 are de-
scribed [28–30]. No differences in participation in life
activities (physical function, travel, recreation, freedom
and work) were found between patients receiving
haemodialysis or peritoneal dialysis [31]. Pre-dialysis pa-
tients (stage 4) also already experience work-related
problems. A Dutch study showed that only 35 % of the
patients, aged 18–64 years, had a paid job at the start of
the treatment [32]. In addition to problems completing
paid work, around 30 % of the pre-dialysis patients
(stage 4) and more than 50 % of the dialysis patients
(stage 5) reported stressors with respect to work [33].
The literature does not give insight into possible par-
ticipation problems as experienced by patients in stage
3. Our study shows that patients with less severe renal
failure (GFR between 30 and 45, stage 3), already experi-
ence problems with continuing their work as a result of
experienced fatigue. They have to make tough decisions
regarding their work, which causes a lot of emotions.
This study shows, in line with social research, that losing
your job does not only lead to a loss of economic self-
sufficiency and the loss of income, but it also leads to a
loss of identity [34]. This loss of identity or loss of self
makes it difficult to accept the diagnosis and integrate it
into the patients’ lives [35, 36]. This loss of identity and
other losses can be a difficult process and patients in our
study were keen on avoiding this situation of loss of
work and possibly their identity by trying to overcom-
pensate and by pushing themselves to the limit. It seems
important to give more attention to the work problems
people with moderate CKD (stage 3) may experience, es-
pecially because of the significant impact on identity
[34] and the influence of income on QoL [4]. Attention
should be given to the problems as experienced in order
to prevent further problems and the possibility of in-
creasing loss of participation.
The final main finding is the wish to have control. Par-
ticipants wanted to do something to stop or slow the pro-
gression of the disease and most of the time, they show
considerable amounts of resilience. Not being able to do
something created a sense of loss of control and influ-
enced the experienced resilience. The focus on doing the
things you can in order to prevent further problems is in
line with the underlying ideas of the Chronic Care Model
and self-management. The Chronic Care Model stresses
the importance of proactive care focused on supporting
people’s ability to self-manage their health [37]. The model
advocates an active role for patients, who are encouraged
to become more knowledgeable about factors affecting
their condition(s) and become more actively involved in
decisions about their care [37].
Self-management has also gained more and more at-
tention in the care of patients with CKD/ESRD. Most
programmes are, however, aimed at the pre-dialysis and
dialysis stages (e.g. [38]), rather than at this stage. Partic-
ipants were very dissatisfied with the fact that they did
not receive advice on how to change their lifestyle. Ad-
vice is only suggested and supported at the pre-dialysis
stage. Participants received this too late.
Conclusions
This study gives new insights into an expanding group
of patients (http://www.ekha.eu) with CKD that has not
yet attracted much research attention. Information about
this group has not yet been described in the literature.
Critical readers may mention that this study is ‘just’ a
qualitative study, which makes the results difficult to
generalise. The sample size was indeed relatively small
compared with that of a quantitative study, but it was
very reasonable for a qualitative one. The results can be
seen as valid since we reached saturation [39, 40].
Nevertheless, the readers must decide whether the re-
sults are recognisable and applicable for their practice
and which results can be used in their own practice
of working with patients with CKD. Future quantita-
tive research can help us to further validate the find-
ings of this study.
Meanwhile, this study gives many rich insights into
the experiences and life-world of patients with a
moderate-to-severe renal function. Such insights were
lacking and are needed to improve healthcare and the
QoL of this group of patients. Ideally, professionals
should be more aware of the problems patients already
may experience in earlier stages of the disease and how
these problems may influence QoL. They should ask
patients about possible problems and they should
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acknowledge and not devaluate those problems, giving
patients the support they need in order to solve prob-
lems as much as possible. Giving attention to the prob-
lems experienced by patients and trying to solve those
problems is in line with a relative new trend in health-
care: personalised care planning.
Personalised care planning is a collaborative pro-active
process used in the management of chronic diseases in
which patients and professionals identify and discuss
problems caused by or related to the patient’s condition,
developing a plan for tackling these. In essence, it is a
conversation or series of conversations, in which they
jointly agree on goals and actions for managing the pa-
tient’s condition [37]. Personalised care planning aims at
ensuring that the individuals’ values and concerns that
shape the way long-term conditions are managed.
Instead of focusing on a standard set of disease manage-
ment processes determined by healthcare professionals,
this approach encourages patients to select treatment
goals and work with clinicians to determine their specific
needs for treatment and support [37]. The results from
this study can be used to set goals. The results also pin-
point the importance of holistic care, as Mangin previously
described. Ideally the care for people with multiple long-
term conditions like CKD should be holistic, which means
person-centred rather than disease-focused. It should be
responsive to individuals’ experiences of illness and treat-
ment effects and persons’ individual priorities [37]. Perso-
nalised care planning leads to people’s increased capability
to self-manage their condition when compared to usual
care, as described in a recent systematic review [37].
Ethics and consent to participate
The Medical Ethics Committee of the VU Medical Cen-
ter approved this study and the procedures followed
were in accordance with the ethical standards of the
Medical Ethics Committee of the VU Medical Center.
All participants voluntarily took part and none of them
declined our request to participate. All participants gave
verbal informed consent.
Consent to publish
All participants gave consent for using their interviews
anonymously.
Availability of data and materials





 Background and objectives research
 Audio recording: explanation goal and getting
consent?
 Privacy and use of data and right to stop the
interview or to skip questions
Background participant
 Actual daily activities: (voluntary) work, hobbies, et
cetera
 Work, education (history)
 Family setting/Matrimony
Illness history
 Diagnosis (including heredity)
 Actual treatment and treatment history
 Co-morbidity?
 Actual health status (GFR, complaints)
Eventual influence of disease on quality of life
 Daily activities (ADL and housekeeping)
 Social contacts and intimate relationships
(including sexuality)
 Childwish and family life
 Hobbies and sport activities




 Actual received care and care history
 Experiences with care
 Needs and wishes regarding care and support
 Possible suggestions for improvement of care/
support
 Possible suggestions for support by patient
organisation
Coping





1) Welcome, goals of the study and today (validation
of results and formulation of recommendations),
consent and consent for audio recording, privacy
2) Filling in the CIS-fatigue
3) Getting to know each other
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4) Validation of results: participants receive an envelope
with the themes as found in the interviews.
Participants are asked to attach each theme on the
red or green piece of paper on the wall. If they
recognize the theme, they attach it on the green
paper and if they do not recognize the theme, they
attach it on the red paper. Themes that are missed
have to be written down on the white paper.
5) Dialogue about step 3: finding similarities and
differences and pinpointing the most important
themes.
6) Formulation of recommendations based on the
findings.
7) Conclusions, evaluation closing remarks (including
giving of small attention for participants and
explain how to declare the travel costs) and check
needs of participants after this session/emotional
impact (f.i. do we need to call tomorrow).
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